Get Started

DYN

NASD Dyne Therapeutics Inc
Oct 28, 2026 · 7:45 AM ET LAST TRADE Market Closed

$16.58 ↓ -0.36 (-2.13%) Trading Down from the previous close of $16.94

YTD change
-15.24%
vs 20-day SMA
+5.47%
vs 200-day SMA
-14.16%

Price ranges

Previous day
$15.73 $16.97
open $15.91 close $16.94
+$1.03 (+6.47%)
Today
$0.00 $0.00
$16.58
Past week
$15.32 $16.97
from $16.27 now $16.58
+$0.31 (+1.91%)
Past month
$14.13 $17.31
from $16.21 now $16.58
+$0.37 (+2.28%)
This year
$14.00 $27.31
from $19.56 now $16.58
-$2.98 (-15.24%)

Price & Performance

-1.22 (-6.72%) / 6M

$13.25$18.09$22.94$27.78Apr 28Jul 29Oct 27

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 65.1% away from all-time highs of $47.45
  • DYN is down 15% since the beginning of the year
  • DYN is down 32% over the past 12 months
  • DYN is up 2% over the past 1 month
  • 15% of all DYN investors are betting against DYN

DYN reads neutral: price sits above one of the two key moving averages, the 12-month move is -30.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.08
Earnings momentum -18.4% Quarterly EPS growth
Quarterly change -18.4%

Valuation

P/E ratio N/A
Enterprise value $2.1B
Beta 2.31

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$898.5M
Debt$233.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.1B

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.95 +0.75%
MRNA Moderna, Inc. $207.97 +4.59%
RVMD Revolution Medicines, Inc. $186.22 +1.26%
ROIV Roivant Sciences Ltd. $36.54 +1.36%
BNTX BioNTech SE Sponsored ADR $87.06 +0.23%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.